BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 23714312)

  • 1. Thrombotic thrombocytopenic purpura and the atypical hemolytic uremic syndrome: an update.
    Tsai HM
    Hematol Oncol Clin North Am; 2013 Jun; 27(3):565-84. PubMed ID: 23714312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic infections mimicking thrombotic thrombocytopenic purpura.
    Booth KK; Terrell DR; Vesely SK; George JN
    Am J Hematol; 2011 Sep; 86(9):743-51. PubMed ID: 21850657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Differential Diagnosis and Treatment of Thrombotic Microangiopathies.
    Bommer M; Wölfle-Guter M; Bohl S; Kuchenbauer F
    Dtsch Arztebl Int; 2018 May; 115(19):327-334. PubMed ID: 29875054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic dilemma in postpartum associated hemolytic uremic syndrome in a 38th week pregnant 31-year-old Congolese: a case report.
    Tshilanda M; Kanmounye US; Tendobi C; Mbuyi F
    BMC Pregnancy Childbirth; 2020 Aug; 20(1):495. PubMed ID: 32854648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical haemolytic uraemic syndrome in a postpartum patient.
    Hierholzer A; Majdinasab E; Young M; Kauffman RP
    BMJ Case Rep; 2023 Nov; 16(11):. PubMed ID: 37945276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple major morbidities and increased mortality during long-term follow-up after recovery from thrombotic thrombocytopenic purpura.
    Deford CC; Reese JA; Schwartz LH; Perdue JJ; Kremer Hovinga JA; Lämmle B; Terrell DR; Vesely SK; George JN
    Blood; 2013 Sep; 122(12):2023-9; quiz 2142. PubMed ID: 23838348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How I treat thrombotic thrombocytopenic purpura and atypical haemolytic uraemic syndrome.
    Scully M; Goodship T
    Br J Haematol; 2014 Mar; 164(6):759-66. PubMed ID: 24387053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: clinically differentiating the thrombotic microangiopathies.
    Cataland SR; Wu HM
    Eur J Intern Med; 2013 Sep; 24(6):486-91. PubMed ID: 23739653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mechanistic approach to the diagnosis and management of atypical hemolytic uremic syndrome.
    Tsai HM
    Transfus Med Rev; 2014 Oct; 28(4):187-97. PubMed ID: 25280590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and management of complement mediated thrombotic microangiopathies.
    Cataland SR; Wu HM
    Blood Rev; 2014 Mar; 28(2):67-74. PubMed ID: 24534133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers of terminal complement activation confirm the diagnosis of aHUS and differentiate aHUS from TTP.
    Cataland SR; Holers VM; Geyer S; Yang S; Wu HM
    Blood; 2014 Jun; 123(24):3733-8. PubMed ID: 24695849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical hemolytic uremic syndrome.
    Kavanagh D; Goodship TH; Richards A
    Semin Nephrol; 2013 Nov; 33(6):508-30. PubMed ID: 24161037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombotic microangiopathies (TTP, HUS, HELLP).
    Kappler S; Ronan-Bentle S; Graham A
    Emerg Med Clin North Am; 2014 Aug; 32(3):649-71. PubMed ID: 25060255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How I treat: the clinical differentiation and initial treatment of adult patients with atypical hemolytic uremic syndrome.
    Cataland SR; Wu HM
    Blood; 2014 Apr; 123(16):2478-84. PubMed ID: 24599547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombotic microangiopathies.
    Rosove MH
    Semin Arthritis Rheum; 2014 Jun; 43(6):797-805. PubMed ID: 24360024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eculizumab therapy leads to rapid resolution of thrombocytopenia in atypical hemolytic uremic syndrome.
    Tsai HM; Kuo E
    Adv Hematol; 2014; 2014():295323. PubMed ID: 25400666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical Hemolytic Uremic Syndrome: Differential Diagnosis from TTP/HUS and Management.
    Yenerel MN
    Turk J Haematol; 2014 Sep; 31(3):216-25. PubMed ID: 25319590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamics of complement activation in aHUS and how to monitor eculizumab therapy.
    Noris M; Galbusera M; Gastoldi S; Macor P; Banterla F; Bresin E; Tripodo C; Bettoni S; Donadelli R; Valoti E; Tedesco F; Amore A; Coppo R; Ruggenenti P; Gotti E; Remuzzi G
    Blood; 2014 Sep; 124(11):1715-26. PubMed ID: 25037630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement activation in diseases presenting with thrombotic microangiopathy.
    Meri S
    Eur J Intern Med; 2013 Sep; 24(6):496-502. PubMed ID: 23743117
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.